Dosing considerations in the use of the direct oral anticoagulants in the antiphospholipid syndrome.
What is known and objectives At least four prospective trials have been initiated investigating the direct oral anticoagulants in the antiphospholipid syndrome. Preliminary reports have supported their use in patients with a history of venous thrombosis and a target INR of 2-3, but there have also b...
| Publicado en: | Journal of Clinical Pharmacy & Therapeutics Vol. 43; no. 1; pp. 104 - 107 |
|---|---|
| Autores principales: | , |
| Formato: | case study Journal Article |
| Publicado: |
Wiley-Blackwell
Feb2018
|
| Acceso en línea: | Ver este registro en EBSCOhost |